Epigenetic reprogramming in adaptive drug resistance to BRAF inhibitor therapy
Ontology highlight
ABSTRACT: The development of drug resistance is a major limiting factor to the efficacy of BRAF inhibitor therapy for melanoma. The goal of this study was to identify and characterize pathways that contribute to adaptive drug resistance to BRAF inhibitors.
ORGANISM(S): Homo sapiens
PROVIDER: GSE156302 | GEO | 2021/12/31
REPOSITORIES: GEO
ACCESS DATA